BRIEF: Abbisko moves into the black in 2024
Biopharmaceutical company Abbisko Cayman Ltd. (2256.HK) said on Monday that its revenue increased significantly last year, up from 19 million yuan ($2.59 million) in 2023 to 485 million yuan in…
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
Shares of cancer drug startup, whose investors include Carlyle Group and Temasek, are down 7% a week after their trading debut Key takeaways Four rounds of fundraising together with IPO…
RECENT ARTICLES
-
BRIEF: Haitian Flavoring reports 2024 double-digit profit growth as it moves toward Hong Kong IPO
603288.SHG -
Baozun returns to the black as Gap expansion accelerates
9991.HK BZUN.US
-
Black Sesame emerges as dark horse in driving technology race
2533.HK
-
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK
-
Its knuckles rapped, recovering Gaotu springs back to the black
GOTU.US
-
DPC Dash serves up banner 2024 topped with milestones
1405.HK
-
Dingdong rings up strong end to 2024, but warns of turbulence ahead
DDL.US
